Ardena will be exhibiting at BIO-Europe 2023, Europe’s flagship partnering event, taking place from November 6–8 in Munich, Germany.
Meet Our Expert Team at Booth 278:
- Mark van Eldijk, Business Unit Director Nanomedicine
- Bastiaan Buddingh’, Business Development Manager, Nanomedicine
- Stefan Einarsson, Business Development Director, Drug Substance
- Juris Fotins, Business Development Director, Drug Substance
- Lucía Erroba López, Business Development Manager, Drug Product
- Niels Nijstad, Business Development Manager, Bioanalysis
Our dedicated team at this event is ready to discuss new collaborations. As a fully integrated CDMO, Ardena is your key partner in bringing molecules to the clinics.
What Can Ardena Offer Biotechs at BIO-Europe?
- Small molecule API projects, from route scouting to accelerated manufacturing
- Phase-appropriate drug product development and manufacturing
- Expertise in bioavailability enhancement, HPAPI, andcontrolled substances
- Comprehensive bioanalytical expertise
- Packaging and logistics for clinical trials
- Leading nanomedicine development and manufacturing services
- Expert CMC regulatory support
We’re not just a CDMO; we’re your one-source partner in navigating the complex world of drug development. Our integrated services, agile operations, and dossier-centric approach ensure a smooth journey from molecule to clinic.
Request a meeting with our team via BIO-Europe’s partnering system, visit us at Booth 278 or fill the contact form in this page.